Literature DB >> 10401921

Isotretinoin treatment of a woman with bipolar disorder.

A D Cott, K L Wisner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10401921     DOI: 10.4088/jcp.v60n0611a

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  7 in total

Review 1.  Retinoic acid and affective disorders: the evidence for an association.

Authors:  J Douglas Bremner; Kirsty D Shearer; Peter J McCaffery
Journal:  J Clin Psychiatry       Date:  2011-08-23       Impact factor: 4.384

Review 2.  Inter-relationships between isotretinoin treatment and psychiatric disorders: Depression, bipolar disorder, anxiety, psychosis and suicide risks.

Authors:  Maude Ludot; Stephane Mouchabac; Florian Ferreri
Journal:  World J Psychiatry       Date:  2015-06-22

Review 3.  The neurobiology of retinoic acid in affective disorders.

Authors:  J Douglas Bremner; Peter McCaffery
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-07-10       Impact factor: 5.067

4.  Obsessive-compulsive disorder with bipolar diathesis following isotretinoin therapy remitting upon treatment with olanzapine and fluvoxamine.

Authors:  Michele Fornaro
Journal:  Neuropsychiatr Dis Treat       Date:  2010-10-29       Impact factor: 2.570

5.  The effect of isotretinoin (roaccutane) therapy on depression and quality of life of patients with severe acne.

Authors:  Youssef Fakour; Pedram Noormohammadpour; Hamed Ameri; Amir Houshang Ehsani; Leila Mokhtari; Najmeh Khosrovanmehr; Seyedeh Zahra Hoseini Nezhad
Journal:  Iran J Psychiatry       Date:  2014-10

6.  Acute psychosis induced by isotretinoin.

Authors:  Sundararajan Rajagopal
Journal:  Indian J Psychiatry       Date:  2014-07       Impact factor: 1.759

7.  Isotretinoin and psychopathology: a review.

Authors:  Vassilis P Kontaxakis; Demetris Skourides; Panayotis Ferentinos; Beata J Havaki-Kontaxaki; George N Papadimitriou
Journal:  Ann Gen Psychiatry       Date:  2009-01-20       Impact factor: 3.455

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.